Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Samy Selim, Mha Albqmi, Awadh Alanazi, Yasir Alruwaili, Mohammad M. Al-Sanea, Taghreed S. Alnusaire, Mohammed S. Almuhayawi, Soad K. Al Jaouni, Shaimaa Hussein, Mona Warrad, Hamada AbdElgawad, Naglaa Elshafey & Mohamed E. Elnosary. (2023) Antiviral activities of olive oil apigenin and taxifolin against SARS-CoV-2 RNA-dependent RNA polymerase (RdRP): In silico, pharmacokinetic, ADMET, and in-vitro approaches. Cogent Food & Agriculture 9:1.
Read now
Read now
Mala Rajendran, Sudeep Roy, Keerthana Ravichandran, Bagdevi Mishra, Deepak K. Gupta, Subash Nagarajan, Ruby Celsia Arul Selvaraj & Ivo Provaznik. (2022) In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro. Journal of Biomolecular Structure and Dynamics 40:7, pages 3155-3169.
Read now
Read now
Jiarui Li & Ester Boix. (2021) Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses. Virulence 12:1, pages 444-469.
Read now
Read now
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar & Sushabhan Sadhukhan. (2021) Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: an in-silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6249-6264.
Read now
Read now
Mallikarjuna Nimgampalle, Vasudharani Devanathan & Ambrish Saxena. (2021) Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. Journal of Biomolecular Structure and Dynamics 39:14, pages 4949-4961.
Read now
Read now
Abdo A. Elfiky. (2021) SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. Journal of Biomolecular Structure and Dynamics 39:9, pages 3204-3212.
Read now
Read now
Abdo A. Elfiky & Eman B. Azzam. (2021) Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics 39:8, pages 2923-2931.
Read now
Read now
Alessandro Sinigaglia, Silvia Riccetti, Marta Trevisan & Luisa Barzon. (2018) In silico approaches to Zika virus drug discovery. Expert Opinion on Drug Discovery 13:9, pages 825-835.
Read now
Read now
A. A. Elfiky & A. M. Ismail. (2018) Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures. SAR and QSAR in Environmental Research 29:5, pages 409-418.
Read now
Read now
Articles from other publishers (29)
Elena Kazakova, Thomas R. Lane, Thane Jones, Ana C. Puhl, Olga Riabova, Vadim Makarov & Sean Ekins. (2023)
1-Sulfonyl-3-amino-1
H
-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
. ACS Omega 8:45, pages 42951-42965.
Crossref
Crossref
Irfan Gul, Amreena Hassan, Ehtishamul Haq, Syed Mudasir Ahmad, Riaz Ahmad Shah, Nazir Ahmad Ganai, Naveed Anjum Chikan, Mohamed Faizal Abdul-Careem & Nadeem Shabir. (2023) An Investigation of the Antiviral Potential of Phytocompounds against Avian Infectious Bronchitis Virus through Template-Based Molecular Docking and Molecular Dynamics Simulation Analysis. Viruses 15:4, pages 847.
Crossref
Crossref
Raghav Mishra, Kajal Chaudhary & Isha Mishra. (2023) Weapons and Strategies against COVID-19: A Perspective. Current Pharmaceutical Biotechnology 25:2, pages 144-158.
Crossref
Crossref
Ahmad ALSULIMANI, Tulika BHARDWAJ, Essam M. JANAHI, Atiah H. ALMALKI, Brij N. TEWARI, Mohd WAHID, Mustfa F. ALKHANANI, Pallavi SOMVANSHI & Shafiul HAQUE. (2022) Systematic structure guided clustering of chemical lead compounds targeting RdRp of SARS-CoV-2. Minerva Biotechnology and Biomolecular Research 34:3.
Crossref
Crossref
Farag E.S. Mosa, Ayman O.S. El-Kadi & Khaled Barakat. 2022. High-Throughput Screening for Drug Discovery. High-Throughput Screening for Drug Discovery.
Abdo A. Elfiky, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim & Wael M. Elshemey. (2022) Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase. RSC Advances 12:5, pages 2741-2750.
Crossref
Crossref
Shabir Ahmad Mir, Ahmad Firoz, Mohammed Alaidarous, Bader Alshehri, Abdul Aziz Bin Dukhyil, Saeed Banawas, Suliman A Alsagaby, Wael Alturaiki, Gulzar Ahmad Bhat, Faizan Kashoo & Ahmad M Abdel-Hadi. (2022) Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach. Saudi Journal of Biological Sciences 29:1, pages 394-401.
Crossref
Crossref
Jelena Đorović Jovanović, Nedeljko Manojlović & Zoran Marković. (2021) Usnic Acid as a Potential Free Radical Scavenger and its Inhibitory Activity Toward SARS-CoV-2 Proteins. Journal of Computational Biophysics and Chemistry 20:06, pages 655-666.
Crossref
Crossref
Victor O. Gawriljuk, Daniel H. Foil, Ana C. Puhl, Kimberley M. Zorn, Thomas R. Lane, Olga Riabova, Vadim Makarov, Andre S. Godoy, Glaucius Oliva & Sean Ekins. (2021) Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus. Journal of Chemical Information and Modeling 61:8, pages 3804-3813.
Crossref
Crossref
Sanjay Kumar Singh, Atul Kumar Upadhyay & M. Sudhakara Reddy. (2021) Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach. 3 Biotech 11:2.
Crossref
Crossref
Ajay Pal, James F. Curtin & Gemma K. Kinsella. (2021) In silico and in vitro screening for potential anticancer candidates targeting GPR120. Bioorganic & Medicinal Chemistry Letters 31, pages 127672.
Crossref
Crossref
Sraa Abu-Melha, Mastoura M. Edrees, Sayed M. Riyadh, Mohamad R. Abdelaziz, Abdo A. Elfiky & Sobhi M. Gomha. (2020) Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro). Molecules 25:19, pages 4565.
Crossref
Crossref
Marian Rofeal & Fady Abd El-Malek. (2020) Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment. Medical Hypotheses 143, pages 109904.
Crossref
Crossref
Abdo A. Elfiky. (2020) Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences 253, pages 117592.
Crossref
Crossref
Abdo A. Elfiky. (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences 248, pages 117477.
Crossref
Crossref
Congshan Liu, Jianhai Yin, Jiaqing Yao, Zhijian Xu, Yi Tao & Haobing Zhang. (2020) Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Pedro Pereira Lira Furtado de Albuquerque, Lucianna H.S. Santos, Deborah Antunes, Ernesto Raul Caffarena & Andreza Soriano Figueiredo. (2020) Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors. Virus Research 278, pages 197867.
Crossref
Crossref
Alaa M. Ismail, Abdo A. Elfiky & Wael M. Elshemey. (2019) Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective. Journal of Molecular Recognition 33:3.
Crossref
Crossref
Abdo A. Elfiky. (2019) Novel guanosine derivatives against Zika virus polymerase in silico. Journal of Medical Virology 92:1, pages 11-16.
Crossref
Crossref
Jeffrey R. Wagner, Christopher P. Churas, Shuai Liu, Robert V. Swift, Michael Chiu, Chenghua Shao, Victoria A. Feher, Stephen K. Burley, Michael K. Gilson & Rommie E. Amaro. (2019) Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking. Structure 27:8, pages 1326-1335.e4.
Crossref
Crossref
Renata P.C. Barros, Luciana Scotti & Marcus T. Scotti. (2019) Exploring Secondary Metabolites Database of Apocynaceae, Menispermaceae, and Annonaceae to Select Potential Anti-HCV Compounds. Current Topics in Medicinal Chemistry 19:11, pages 900-913.
Crossref
Crossref
Muhammad Usman Mirza, Michiel Vanmeert, Matheus Froeyen, Amjad Ali, Shazia Rafique & Muhammad Idrees. (2019) In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors. Scientific Reports 9:1.
Crossref
Crossref
Gabriela Bitencourt-Ferreira & Walter Filgueira de Azevedo. 2019. Docking Screens for Drug Discovery. Docking Screens for Drug Discovery
149
167
.
Isabella Romeo, Nadia Marascio, Grazia Pavia, Carmine Talarico, Giosuè Costa, Stefano Alcaro, Anna Artese, Carlo TortiMaria Carla Liberto & Alfredo Focà. (2018) Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct‐Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity. ChemistrySelect 3:21, pages 6009-6017.
Crossref
Crossref
Abdo A. Elfiky & Wael M. Elshemey. (2018) Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds. Journal of Medical Virology 90:1, pages 13-18.
Crossref
Crossref
Garima Jindal, Dibyendu Mondal & Arieh Warshel. (2017) Exploring the Drug Resistance of HCV Protease. The Journal of Physical Chemistry B 121:28, pages 6831-6840.
Crossref
Crossref
Abdo A Elfiky & Alaa M Ismail. (2017) Molecular modeling and docking revealed superiority of IDX-184 as HCV polymerase inhibitor. Future Virology 12:7, pages 339-347.
Crossref
Crossref
Khaled Barakat. (2017) Solubility: A Speed-Breaker on the Drug Discovery Highway. MOJ Bioequivalence & Bioavailability 3:3.
Crossref
Crossref
Jeffrey R. Wagner, Christopher P. Churas, Shuai Liu, Robert V. Swift, Michael Chiu, Chenghua Shao, Victoria A. Feher, Stephen K. Burley, Michael K. Gilson & Rommie E. Amaro. (2018) Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking. SSRN Electronic Journal.
Crossref
Crossref